Background Background Chinese herbal medicine
Chinese herbal medicine has been used to treat millions of people has been used to treat millions of people with schizophrenia for thousands of years. with schizophrenia for thousands of years.
Aims Aims To evaluate Chinese herbal
To evaluate Chinese herbal medicine as a treatment for schizophrenia. medicine as a treatment for schizophrenia.
Method
Method A systematic review of A systematic review of randomised controlled trials (RCTs). randomised controlled trials (RCTs).
Results
Results Seven trials were included.
Seven trials were included. Most studies evaluated Chinese herbal Most studies evaluated Chinese herbal medicine in combination with Western medicine in combination with Western antipsychotic drugs; in these trials results antipsychotic drugs; in these trials results tended to favour combination treatment tended to favour combination treatment compared with antipsychotic alone compared with antipsychotic alone (Clinical Global Impression'not improved/ (Clinical Global Impression'not improved/ worse' worse'n n¼123,RR 123,RR¼0.19,95% CI 0.1^0.6, 0.19,95% CI 0.1^0.6, NNT NNT¼6,95% CI 5^11; 6,95% CI 5^11; n n¼109,Brief 109,Brief Psychiatric Rating Scale'not improved/ Psychiatric Rating Scale'not improved/ worse'RR worse'RR¼0.78,95% CI 0.5^1. 2; 0.78,95% CI 0.5^1.2; n n¼109, 109, Scale for the Assessment of Negative Scale for the Assessment of Negative Symptoms'not improved/worse' Symptoms'not improved/worse' RR RR¼0.87,95% CI 0.7^1. 2; 0.87,95% CI 0.7^1.2; n n¼109, Scale for 109, Scale for the Assessment of Positive Symptoms'not the Assessment of Positive Symptoms'not improved/worse'RR improved/worse'RR¼0.69, 95% CI 0.50.69,95% CI 0.51 .0,NNT 1.0,NNT¼6 95% CI 4^162).Medium-term 6 95% CI 4^162).Medium-term study attrition was significantly less for study attrition was significantly less for people allocated the herbal/antipsychotic people allocated the herbal/antipsychotic mix ( mix (n n¼897, four RCTs,RR 897, four RCTs,RR¼0.34,95% CI 0.34, 95% CI 0.2^0.7,NNT 0.2^0.7,NNT¼23,95% CI18^43).
23,95% CI18^43).
Conclusions Conclusions Results suggestthat
Results suggestthat combining Chinese herbal medicine with combining Chinese herbal medicine with antipsychotics is beneficial. antipsychotics is beneficial.
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Chinese medicine, now commonly referred Chinese medicine, now commonly referred to as 'traditional Chinese medicine' has to as 'traditional Chinese medicine' has been used to treat schizophrenia-like illness been used to treat schizophrenia-like illness for over 2000 years (Ming, 2001) . for over 2000 years (Ming, 2001) . Although antipsychotic drugs are the mainAlthough antipsychotic drugs are the mainstay of treatment both in China and in the stay of treatment both in China and in the West, they are associated with serious West, they are associated with serious adverse effects such as tardive dyskinesia adverse effects such as tardive dyskinesia and tremor. In addition, about 20% of peoand tremor. In addition, about 20% of people do not respond adequately to treatment ple do not respond adequately to treatment (Brenner (Brenner et al et al, 1990) . Some earlier reports , 1990). Some earlier reports have suggested that Chinese herbal medihave suggested that Chinese herbal medicine is effective for psychosis and that comcine is effective for psychosis and that combination treatments (drugs plus herbs) are bination treatments (drugs plus herbs) are useful to enhance antipsychotic efficacy or useful to enhance antipsychotic efficacy or reduce the period of recovery and adverse reduce the period of recovery and adverse effects (Saku, 1991; Wang, 1998 effects (Saku, 1991 Wang, 1998a a) . ).
The methodology used in traditional The methodology used in traditional Chinese medicine to diagnose and treat Chinese medicine to diagnose and treat schizophrenia differs from that used in schizophrenia differs from that used in Western medicine. Traditional Chinese Western medicine. Traditional Chinese medicine differentiates cases of schizomedicine differentiates cases of schizophrenia into syndromes, and it is these phrenia into syndromes, and it is these syndromes rather than the disease label syndromes rather than the disease label such as schizophrenia or such as schizophrenia or dian kuang dian kuang (with-(withdrawal mania), that determine treatment drawal mania), that determine treatment (Fig. 1 ). There are five main syndromes that (Fig. 1 ). There are five main syndromes that fall within the disease category of fall within the disease category of dian dian kuang kuang which may also include the Western which may also include the Western diagnosis of schizophrenia. The five types diagnosis of schizophrenia. The five types are: are:
(a) (a) phlegm-fire; phlegm-fire; (Zhang, 1996 (Zhang, ). 1996 .
Each syndrome has a specific herbal Each syndrome has a specific herbal formulation, but patients typically have formulation, but patients typically have mixed clinical presentations requiring mixed clinical presentations requiring formulas to be adapted by adding or subformulas to be adapted by adding or subtracting herbs. To complicate matters, in tracting herbs. To complicate matters, in China herbal medicines are sometimes used China herbal medicines are sometimes used within the Western diagnostic paradigm within the Western diagnostic paradigm alone without incorporating traditional alone without incorporating traditional theory. Nevertheless, because of the enortheory. Nevertheless, because of the enormous population of China, even if herbal mous population of China, even if herbal medicines are given to only a small propormedicines are given to only a small proportion of the estimated 13 million Chinese tion of the estimated 13 million Chinese people with schizophrenia, these treatment people with schizophrenia, these treatment approaches could still be some of the most approaches could still be some of the most prevalent used for this illness. prevalent used for this illness.
METHOD METHOD
Full details of all methods used and the preFull details of all methods used and the predefined inclusion criteria are published elsedefined inclusion criteria are published elsewhere (Rathbone where (Rathbone et al et al, 2005 (Rathbone et al et al, 2005) . , 2005). Data were not utilised from studies in Data were not utilised from studies in which more than 50% of participants in which more than 50% of participants in any group were lost to follow-up (this does any group were lost to follow-up (this does not include the outcome of 'leaving the not include the outcome of 'leaving the study early'). In studies with a less than study early'). In studies with a less than 50% withdrawal rate people leaving the 50% withdrawal rate people leaving the study early were considered to have had study early were considered to have had the negative outcome, except for the event the negative outcome, except for the event of adverse effects and death. For binary of adverse effects and death. For binary outcomes, the fixed-effects relative risk outcomes, the fixed-effects relative risk and its 95% confidence interval were calcuand its 95% confidence interval were calculated. The numbers needed to treat/harm lated. The numbers needed to treat/harm (NNT/NNH) were also calculated. An esti-(NNT/NNH) were also calculated. An estimate of the weighted mean difference mate of the weighted mean difference (WMD) between groups and its 95% confi-(WMD) between groups and its 95% confidence interval were calculated for continudence interval were calculated for continuous data. Data were not pooled if ous data. Data were not pooled if standard deviations were too wide, suggeststandard deviations were too wide, suggesting considerable skew (Altman & Bland, ing considerable skew (Altman & Bland, 1996) . Heterogeneity between studies was 1996). Heterogeneity between studies was R ATHBONE E T AL R ATHB ONE E T AL assessed by inspecting the relevant graph; assessed by inspecting the relevant graph; this was supplemented using the this was supplemented using the I I . If inconsistency was high ( high (5 575%), the data were not pooled 75%), the data were not pooled but were presented separately and the but were presented separately and the reasons for heterogeneity investigated. reasons for heterogeneity investigated.
Citations were inspected independently Citations were inspected independently by at least two reviewers. The reliability by at least two reviewers. The reliability of the data extraction was checked using a of the data extraction was checked using a 10% sample. Full reports of studies of 10% sample. Full reports of studies of agreed relevance were obtained, qualityagreed relevance were obtained, qualityrated (Alderson rated and data ex-, 2004) and data extracted for details of methods, participants, tracted for details of methods, participants, interventions and outcomes. Disagreements interventions and outcomes. Disagreements between reviewers were discussed and if between reviewers were discussed and if they could not be resolved further inforthey could not be resolved further information was sought from authors. Main mation was sought from authors. Main outcomes of interest were predefined as outcomes of interest were predefined as clinical response in global or mental state, clinical response in global or mental state, adverse events including extrapyramidal adverse events including extrapyramidal adverse effects, service use including hospiadverse effects, service use including hospitalisation and relapse, quality of life, leavtalisation and relapse, quality of life, leaving the study early, death and economic ing the study early, death and economic evaluations. evaluations.
RESULTS RESULTS

Electronic searches resulted in over 640
Electronic searches resulted in over 640 citations but most clearly did not meet the citations but most clearly did not meet the inclusion criteria. Full copies of only 14 inclusion criteria. Full copies of only 14 studies were obtained, of which we could studies were obtained, of which we could include 7 (Table 1) . Of those we excluded, include 7 ( (Zhang et al et al, 1987) . , 1987). All seven included studies were conducted All seven included studies were conducted in China and were described as being in China and were described as being randomised, but none gave a description randomised, but none gave a description of the allocation procedure. Double-blind of the allocation procedure. Double-blind methodology was used in three studies, all methodology was used in three studies, all of which used of which used Ginkgo biloba Ginkgo biloba extract extract (EGb761) combined with antipsychotics. (EGb761) Herbal medicines given according to traHerbal medicines given according to traditional Chinese medicine syndrome differditional Chinese medicine syndrome differentiation -in only one study (Zhang entiation -in only one study (Zhang et al et al, , 1997) , using 1997), using dang gui cheng qi tang dang gui cheng qi tang or or xiao xiao yao san yao san -when combined with anti--when combined with antipsychotic medication (unspecified) scored psychotic medication (unspecified) scored significantly lower for the outcome of significantly lower for the outcome of global state 'not improved/worse' than the global state 'not improved/worse' than the control group given unspecified antipsychocontrol group given unspecified antipsychotics (NNT tics (NNT¼6, 95% CI 5 to 11; Fig. 2(a) ).
6, 95% CI 5 to 11; Fig. 2(a) ). Further global state data from the Clinical Further global state data from the Clinical Global Impression (CGI) scale -Meng Global Impression (CGI) scale -Meng et et al al (1996), unknown antipsychotic; Zhu (1996) , unknown antipsychotic; Zhu et et al al (1996) , chlorpromazine -also favoured (1996), chlorpromazine -also favoured the herbal medicine plus antipsychotic the herbal medicine plus antipsychotic group (Fig. 2(b) ). group ( Fig. 2(b) ).
Zhang Zhang et al et al (2001) found Brief Psychi-(2001) found Brief Psychiatric Rating Scale (BPRS) scores dichotoatric Rating Scale (BPRS) scores dichotomised to 'not improved/worse' were mised to 'not improved/worse' were equivocal ( equivocal (n n¼109, RR 109, RR¼0.78, 95% CI 0.5 0.78, 95% CI 0.5 to 1.2) when to 1.2) when Ginkgo biloba Ginkgo biloba plus haloperiplus haloperidol were compared with haloperidol, as dol were compared with haloperidol, as were data from the Scale for the Assessment were data from the Scale for the Assessment of Negative Symptoms (SANS) ( of Negative Symptoms (SANS) (n n¼109, 109, RR RR¼0.87, 95% CI 0.7 to 1.2). However, 0.87, 95% CI 0.7 to 1.2). However, the Scale for the Assessment of Positive the Scale for the Assessment of Positive Symptoms (SAPS) did slightly favour the Symptoms (SAPS) did slightly favour the herbal medicine plus haloperidol combinaherbal medicine plus haloperidol combination ( tion (n n¼109, RR 109, RR¼0.69, 95% CI 0.5 to 0.69, 95% CI 0.5 to 1.0; NNT 1.0; NNT¼6, 95% CI 4 to 162). Continu-6, 95% CI 4 to 162). Continuous short-term BPRS data -Meng ous short-term BPRS data -Meng et al et al (1996) , unknown antipsychotic; Zhu (1996), unknown antipsychotic; Zhu et al et al (1996) , chlorpromazine -significantly (1996), chlorpromazine -significantly favoured the herbal medicine plus antipsyfavoured the herbal medicine plus antipsychotic combination (Fig. 2(c) ), but data chotic combination (Fig. 2(c) ), but data were heterogeneous ( were heterogeneous (I I 2 2 ¼81%). Medium-81%). Mediumterm BPRS data (Fig. 2(c) ) also favoured term BPRS data (Fig. 2(c) (Fig. 2(d) ) Medium-term SANS scores (Fig. 2(d) AUTHOR'S PROOF AUTHOR'S PROOF significantly favoured the herbal medicine significantly favoured the herbal medicine plus antipsychotic group. plus antipsychotic group. Adverse events are associated with antiAdverse events are associated with antipsychotic medication, and combining herpsychotic medication, and combining herbal medicines with chlorpromazine (Zhu bal medicines with chlorpromazine (Zhu et al et al, 1996) did not mitigate extrapyrami-, 1996) did not mitigate extrapyramidal adverse effects, with both groups being dal adverse effects, with both groups being equivocal. Constipation, however, was equivocal. Constipation, however, was significantly lower in the herbal plus significantly lower in the herbal plus antipsychotic combination group (0/32) antipsychotic combination group (0/32) despite patients receiving the constipating despite patients receiving the constipating antipsychotic chlorpromazine ( antipsychotic chlorpromazine (n n¼67; 67; RR RR¼0.03, 95% CI 0.0 to 0.5; NNH 0.03, 95% CI 0.0 to 0.5; NNH¼2, 2, 95% CI 2 to 4); the comparison group 95% CI 2 to 4); the comparison group (chlorpromazine alone) fared less well (19/ (chlorpromazine alone) fared less well (19/ 35). Medium-term studies found signifi-35). Medium-term studies found significantly fewer patients leaving the study early cantly fewer patients leaving the study early (Fig. 2(e) ) in the herbal plus antipsychotic (Fig. 2(e) ) in the herbal plus antipsychotic group ( group (n n¼897, four RCTs, RR 897, four RCTs, RR¼0.34, 0.34, 95% CI 0.2 to 0.7; NNT 95% CI 0.2 to 0.7; NNT¼23, 95% CI 18 23, 95% CI 18 to 43). to 43).
Sensitivity analysis: Sensitivity analysis: Ginkgo biloba
Ginkgo biloba alone or plus antipsychotics alone or plus antipsychotics v.
v. antipsychotics antipsychotics
Studies of Studies of Ginkgo biloba
Ginkgo biloba were tested in a were tested in a sensitivity analysis by comparing them with sensitivity analysis by comparing them with the original pooled data ( the original pooled data (Ginkgo biloba Ginkgo biloba data pooled with other herbs). Effect sizes data pooled with other herbs). Effect sizes for CGI and BPRS scores were increased for CGI and BPRS scores were increased for for Ginkgo biloba Ginkgo biloba when analysed sepawhen analysed separately, although these differences were not rately, although these differences were not statistically significant. statistically significant.
DISCUSSION DISCUSSION
Six of the seven studies evaluated the use of Six of the seven studies evaluated the use of Chinese herbs for schizophrenia rather than Chinese herbs for schizophrenia rather than traditional Chinese herbal medicine for traditional Chinese herbal medicine for schizophrenia, i.e. treatment was allocated schizophrenia, i.e. treatment was allocated according to a diagnosis of schizophrenia according to a diagnosis of schizophrenia without further differentiation according without further differentiation according to traditional Chinese methodology. Study to traditional Chinese methodology. Study sizes were generally small and pooled data sizes were generally small and pooled data were typically derived from one or two were typically derived from one or two studies. All outcomes, therefore, were studies. All outcomes, therefore, were underpowered. The one study that incorpounderpowered. The one study that incorporated traditional Chinese medical theory rated traditional Chinese medical theory did show significant improvement in global did show significant improvement in global state but was limited by lack of blinding. state but was limited by lack of blinding. There were no descriptions of allocation There were no descriptions of allocation concealment and no assurances that blindconcealment and no assurances that blinding was maintained. The type of antiing was maintained. The type of antipsychotic used and the dosages were often psychotic used and the dosages were often poorly reported, although three studies poorly reported, although three studies used the same herbal interventionused the same herbal intervention -Ginkgo Ginkgo biloba biloba (EGb761). The remainder, however, (EGb761). The remainder, however, used different herbal medicines, and used different herbal medicines, and unfortunately all three unfortunately all three Ginkgo biloba Ginkgo biloba studies studies used different antipsychotic medications. used different antipsychotic medications.
Herbal medicine alone Herbal medicine alone v.
v. antipsychotics antipsychotics Global state measured as 'not improved/ Global state measured as 'not improved/ worse' favoured the chlorpromazine group worse' favoured the chlorpromazine group (NNT with chlorpromazine 4, 95% CI 2 (NNT with chlorpromazine 4, 95% CI 2 to 14) when compared with the treatment to 14) when compared with the treatment group receiving group receiving dang gui cheng qi tang dang gui cheng qi tang. . This NNT concurs with findings when This NNT concurs with findings when chlorpromazine is compared with placebo chlorpromazine is compared with placebo (Adams (Adams et al et al, 2007) ; however, this is based , 2007); however, this is based on a single study ( on a single study (n n¼90; Zhang 90; Zhang et al et al, 1987) , 1987) lasting 20 days with participants given Chilasting 20 days with participants given Chinese herbs according to a diagnosis of nese herbs according to a diagnosis of schizophrenia without using traditional schizophrenia without using traditional Chinese medicine differentiation. Results Chinese medicine differentiation. Results must therefore be interpreted with caution must therefore be interpreted with caution given the design limitations, but neverthegiven the design limitations, but nevertheless do not support less do not support dang gui cheng qi tang dang gui cheng qi tang as a sole treatment for schizophrenia. as a sole treatment for schizophrenia.
Herbal medicine plus Herbal medicine plus antipsychotics antipsychotics v.
v
. antipsychotics antipsychotics
The herbal medicine group receiving either The herbal medicine group receiving either dang gui cheng qi tang dang gui cheng qi tang or or xiao yao san xiao yao san plus plus antipsychotics were significantly less likely antipsychotics were significantly less likely to have an outcome of 'no change or worse' to have an outcome of 'no change or worse' compared with participants receiving only compared with participants receiving only antipsychotics, measured using the Clinical antipsychotics, measured using the Clinical Global Impression scale (NNT Global Impression scale (NNT¼6, 95% CI 6, 95% CI 5 to 11). This could be an important finding 5 to 11). This could be an important finding and does fit with the CGI continuous and does fit with the CGI continuous scores. These results are broadly encourascores. These results are broadly encouraging and suggest that combining herbal ging and suggest that combining herbal medicines with antipsychotics might be medicines with antipsychotics might be beneficial, although results are only based beneficial, although results are only based on two small studies (total on two small studies (total n n¼103). These 103). These vaguely positive finding also apply to menvaguely positive finding also apply to mental state outcomes. The dichotomised BPRS tal state outcomes. The dichotomised BPRS and SANS measures reported by Zhang and SANS measures reported by Zhang et et al al (2001) ; (2001); n n¼109) were equivocal, but 109) were equivocal, but SAPS scores again showed borderline sig-SAPS scores again showed borderline significance in favour of the herbal medicine nificance in favour of the herbal medicine plus antipsychotic combination. Mediumplus antipsychotic combination. Mediumterm continuous SANS data, however, proterm continuous SANS data, however, provided more robust results, with three vided more robust results, with three studies ( studies (n n¼741) favouring the herbal plus 741) favouring the herbal plus antipsychotic combination group. The exantipsychotic combination group. The experimental group had, on average, nine perimental group had, on average, nine points less on this scale than those allocated points less on this scale than those allocated to antipsychotic drugs alone. In our opito antipsychotic drugs alone. In our opinion, in this group of chronically unwell nion, in this group of chronically unwell people such an average difference would people such an average difference would be noticeable and clinically meaningful. be noticeable and clinically meaningful. Further supporting this improvement, both Further supporting this improvement, both short-term and medium-term BPRS scores short-term and medium-term BPRS scores were significantly better for those receiving were significantly better for those receiving herbal medicines plus antipsychotics comherbal medicines plus antipsychotics compared with those receiving antipsychotic pared with those receiving antipsychotic drugs alone, although there was heterogedrugs alone, although there was heterogeneity in these results. The latter might have neity in these results. The latter might have been due to the use of different antibeen due to the use of different antipsychotic drugs between trials. psychotic drugs between trials.
Adverse effect Treatment Emergent Adverse effect Treatment Emergent Signs and Symptoms scores were reported Signs and Symptoms scores were reported by Zhang by Zhang et al et al (2001) , but standard devia-(2001), but standard deviations were wide and no conclusion can be tions were wide and no conclusion can be made with confidence. Only one study made with confidence. Only one study (Zhu (Zhu et al et al, 1996; , 1996 ; n n¼67) reported extra-67) reported extrapyramidal symptoms, and these were not pyramidal symptoms, and these were not significantly different between groups. In significantly different between groups. In one trial in which both groups were given one trial in which both groups were given chlorpromazine, constipation was significhlorpromazine, constipation was significantly more frequent in the control group cantly more frequent in the control group (NNH (NNH¼2). In this trial the herb used was 2). In this trial the herb used was a purgative used also in Western medicine a purgative used also in Western medicine --Rhizoma rhei palmatum Rhizoma rhei palmatum (rhubarb).
(rhubarb). Numbers of participants leaving the Numbers of participants leaving the study early in the short term were similar study early in the short term were similar for both groups. Medium-term data for both groups. Medium-term data showed significantly fewer left early in the showed significantly fewer left early in the herbal medicine plus antipsychotic group herbal medicine plus antipsychotic group compared with people receiving only anticompared with people receiving only antipsychotics ( psychotics (n n¼897; 2% 897; 2% v. v. 7%). In the con-7%). In the context of these studies, the addition of herbal text of these studies, the addition of herbal medicine did not worsen treatment complimedicine did not worsen treatment compliance and there is the suggestion that the ance and there is the suggestion that the addition of the herbal medicine made it addition of the herbal medicine made it easier for participants to take standard easier for participants to take standard antipsychotics. antipsychotics.
We did a We did a post hoc post hoc sensitivity analysis sensitivity analysis for the single herb for the single herb Ginkgo biloba Ginkgo biloba, used , used outside the traditional Chinese medicine outside the traditional Chinese medicine approach within a Western model of approach within a Western model of schizophrenia. We found no evidence that schizophrenia. We found no evidence that this particular herb had remarkable effects. this particular herb had remarkable effects.
The application of traditional Chinese The application of traditional Chinese herbal medicine is fundamentally interherbal medicine is fundamentally interwoven with syndrome differentiation. woven with syndrome differentiation. Failure to apply syndrome differentiation Failure to apply syndrome differentiation may result in treatments being ineffective may result in treatments being ineffective or even harmful. Despite this, there is some or even harmful. Despite this, there is some evidence that these Chinese herbal medievidence that these Chinese herbal medicines, combined with antipsychotics and cines, combined with antipsychotics and given in a way that is not in keeping with given in a way that is not in keeping with their normal use within traditional Chinese their normal use within traditional Chinese medicine, may be beneficial for people with medicine, may be beneficial for people with schizophrenia across a range of outcomes. schizophrenia across a range of outcomes. If these medicines are used within their If these medicines are used within their usual context the positive effects could be usual context the positive effects could be greater. Even the gains seen in this review greater. Even the gains seen in this review would still be important for the millions would still be important for the millions for whom these treatments are used. Both for whom these treatments are used. Both West and East need well-reported (Moher West and East need well-reported (Moher et al et al, 2001 ) randomised trials that are , 2001) randomised trials that are adequately powered, blinded and of suffiadequately powered, blinded and of sufficient duration so we can detect meaningful cient duration so we can detect meaningful
